Zobrazeno 1 - 10 of 89 pro vyhledávání: '"I Merican"'
1
Safety and efficacy of an escalating dose regimen of pegylated interferon alpha-2b in the treatment of haemodialysis patients with chronic hepatitis C
Autor: Soek Siam Tan, Boon Phoe Ooi, M. R. Abu Hassan, Abdul Rahim Abdullah, M. I. Merican, T. Korompis
Publikováno v: Journal of Viral Hepatitis. 17:410-418
Chronic hepatitis C is associated with increased morbidity and mortality in persons undergoing haemodialysis. This single-arm, open-label clinical trial investigated the safety and efficacy of an escalating dosage regimen of pegylated interferon (PEG
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::49e26cf1313b595c4e63866d97d3a4c2
https://doi.org/10.1111/j.1365-2893.2009.01191.x
Zobrazit plný text záznamu
2
Chronic hepatitis B virus infection in Asian countries
Autor: D Amarapuka, Laurentius A. Lesmana, Rn Chien, Richard Guan, A Chutaputti, I Merican, Hs Sun, Nelson Leung, Ss Hasnian, Ph Phiet, Mj Alexander, Hm Sjalfoellah Noer, JD Sollano, Dz Xu
Publikováno v: Journal of Gastroenterology and Hepatology. 15:1356-1361
Of the estimated 50 million new cases of hepatitis B virus (HBV) infection diagnosed annually, 5-10% of adults and up to 90% of infants will become chronically infected, 75% of these in Asia where hepatitis B is the leading cause of chronic hepatitis
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd60cf9f07fbae64038e59e221f5ffe3
https://doi.org/10.1046/j.1440-1746.2000.0150121356.x
Zobrazit plný text záznamu
3
Diurnal pattern of variceal bleeding in cirrhotic patients
Autor: G. Minoli, D. Sprengers, P A McCormick, A.K. Burroughs, I. Merican, Neil McIntyre
Publikováno v: Journal of Hepatology. 19:15-22
The aim of this paper was to assess diurnal periodicity in the time pattern of the time of onset of acute gastrointestinal bleeding related to portal hypertension manifested by hematemesis or melena in cirrhotic patients over a period of 24 h. The st
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c2fbc9802b5a6c30975c3edb8a09c19
https://doi.org/10.1016/s0168-8278(05)80171-0
Zobrazit plný text záznamu
4
Combined assessment of TGF-beta-1 and alpha-fetoprotein values improves specificity in the diagnosis of hepatocellular carcinoma and other chronic liver diseases in Malaysia
Autor: M Y, Yasmin Anum, M L, Looi, A H, Nor Aini, I, Merican, A, Wahidah, A H, Mohd Radzi, A, Nor Azizah, N H, Othman
Publikováno v: The Medical journal of Malaysia. 64(3)
Transforming growth factor beta-1 (TGF-beta-1) is a multifunctional cytokine involved in the regulation of growth and differentiation of both normal and transformed cells. The main aim of this study was to determine whether TGF-beta-1 or alpha fetopr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::909d070e45674e01ac5910258884cbd4
https://pubmed.ncbi.nlm.nih.gov/20527273
Zobrazit plný text záznamu
6
Maternal deaths due to liver disease in Malaysia
Autor: J, Ravindran, R, Jayadev, S R, Lachmanan, I, Merican
Publikováno v: The Medical journal of Malaysia. 55(2)
Liver disease is an important and serious condition in pregnancy. The Confidential Enquiries Into Maternal Deaths in Malaysia showed that there were 23 maternal deaths attributed to liver disease between 1991-1994. Over the same period, there were 10
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::408a9c5d3e2a5b454df58f2c39df9734
https://pubmed.ncbi.nlm.nih.gov/19839149
Zobrazit plný text záznamu
7
Clustering of hypertension, abnormal glucose tolerance, hypercholesterolaemia and obesity in Malaysian adult population
Autor: T O, Lim, L M, Ding, M, Zaki, I, Merican, S T, Kew, A H, Maimunah, H H, Rozita, B, Rugayah
Publikováno v: The Medical journal of Malaysia. 55(2)
We determine the prevalence and determinants of clustering of hypertension, abnormal glucose tolerance, hypercholesterolaemia and overweight in Malaysia. A national probability sample of 17,392 individuals aged 30 years or older had usable data. 61%
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7d6f7621becc6101b648c715c7e70743
https://pubmed.ncbi.nlm.nih.gov/19839148
Zobrazit plný text záznamu
8
Safety and efficacy of an escalating dose regimen of pegylated interferon alpha-2b in the treatment of haemodialysis patients with chronic hepatitis C
Autor: S S, Tan, M R, Abu Hassan, A, Abdullah, B P, Ooi, T, Korompis, M I, Merican
Publikováno v: Journal of viral hepatitis. 17(6)
Chronic hepatitis C is associated with increased morbidity and mortality in persons undergoing haemodialysis. This single-arm, open-label clinical trial investigated the safety and efficacy of an escalating dosage regimen of pegylated interferon (PEG
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::38973d260a23a0c42c28748a44886ecd
https://pubmed.ncbi.nlm.nih.gov/19758272
Zobrazit plný text záznamu
10
Relapse after treatment with peginterferon alpha-2b alone or in combination with lamivudine in HBeAg positive chronic hepatitis B
Autor: H.L.A. Janssen, I Merican, George Kitis, J Cianciara, Frederik Nevens, Hajo J. Flink, B.E. Hansen, Erik H.C.J. Buster, S.W. Schalm, R A de Vries
Publikováno v: Gut, 56(10), 1485-1486. BMJ PUBLISHING GROUP
Gut, 56(10), 1485-1486. BMJ Publishing Group
Interferon induced HBeAg loss is persistent in up to 90% of patients with chronic hepatitis B (HBV).1–3 Older age and vertical transmission have been shown previously to be independent predictors of relapse after conventional IFN.4 Shorter duration
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d95828c33fd16010574d9c6ba2f4d6c
https://pubmed.ncbi.nlm.nih.gov/17872587
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje